The emergence of novel psychoactive substances introduces a unique opportunity for researchers and policymakers alike. Among these, 2-FDCK has risen prominence as a potent dissociative agent with limited pharmacological properties. Initial studies suggest that 2-FDCK may elicit analogous effects to other dissociatives, such as ketamine, but its pre